Trial Profile
A single-blind randomized controlled clinical study comparing the efficacy, tolerability and safety oflevocetrizine and olopatadine in chronic urticaria
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Levocetirizine (Primary) ; Olopatadine (Primary)
- Indications Urticaria
- Focus Therapeutic Use
- 25 Nov 2015 New source identified and integrated (CTRI/2011/08/001965).
- 25 Nov 2015 New trial record